IntraLinks announced the results of the IntraLinks Global Investigator Site Survey. The survey looked at what methods are currently used for clinical trial document exchange, and the effectiveness of those methods. Eighty three percent of the respondents were clinical research coordinators, investigators and subinvestigators.
The survey findings show that the majority of investigator sites are using traditional methods–e-mail, courier, and fax–as a primary tool for clinical trial document exchange. A relatively small number of respondents are using web-based document exchange tools as their primary method:
· 73% of respondents use traditional methods – email (52%), courier (12%) and fax (nine percent)–as their primary tool for clinical trial document exchange
· 25% of respondents use web-based document exchange tools as their main way of exchanging clinical trial documents
The survey results indicate that investigator sites are experiencing significant inefficiencies and productivity challenges as a result of the ongoing use of email, courier and fax:
· 59% of respondents track due dates for information, current status or milestones manually
· 66% of respondents spend at least two hours, and in some cases more than nine hours, per week searching for documents
· 74% of respondents report resending documents to sponsors and Contract Research Organizations (CROs) at least once or twice, and in some cases more than five times, a week
The survey found that respondents recognize the benefits of web-based clinical document exchange tools:
· 68% of respondents cited being able to access updated information right away and reducing the amount of paper they use as advantages
· 62% of respondents cited being able to keep track of information easily as a benefit
· 47% of respondents cited not spending as much time searching for information as a benefit
The survey findings also showed that most respondents are conducting numerous studies and those that use online clinical tools such as electronic data capture and clinical portals have a significant number of passwords and logins:
· 87% of respondents have conducted three to 15+ studies over the last 12 months
· 57% of respondents are running four to 15+ concurrent studies
· 47% of respondents have at least three to ten passwords and logins, while another 20% have more than ten
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.